Literature DB >> 18586922

Pediatric nonrhabdomyosarcoma soft tissue sarcomas.

Sheri L Spunt1, Stephen X Skapek, Cheryl M Coffin.   

Abstract

The nonrhabdomyosarcoma soft tissue sarcomas (NRSTSs) are a heterogeneous group of mesenchymal cell neoplasms that account for about 4% of childhood cancers. Because each histologic subtype of NRSTS is rare, they have been poorly studied and little is known about their biology, natural history, or optimal treatment. Data from adults with soft tissue sarcomas provide some helpful insight, but adult and childhood NRSTSs differ considerably in the distribution of their histologic subtypes, and certain entities are known to behave differently in young children. The greater risks posed to children by treatment, particularly by radiotherapy, also must be considered in treatment planning for children. This article summarizes what is known to date about childhood NRSTS, including the epidemiology, pathogenesis, and clinical approach to diagnosis and treatment of these tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18586922     DOI: 10.1634/theoncologist.2007-0182

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  20 in total

1.  Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) in pediatric and young adult patients: Results from a prospective study using limited-margin radiotherapy.

Authors:  Christopher L Tinkle; Israel Fernandez-Pineda; April Sykes; Zhaohua Lu; Chia-Ho Hua; Michael D Neel; Armita Bahrami; Barry L Shulkin; Sue C Kaste; Alberto Pappo; Sheri L Spunt; Matthew J Krasin
Journal:  Cancer       Date:  2017-07-31       Impact factor: 6.860

2.  Sarcomas in Nigerian Children in Jos North Central Nigeria.

Authors:  M A Dauda; D Yakubu; B M Mandong; E O Ojo
Journal:  Afr J Med Med Sci       Date:  2014-09

3.  Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Fédération Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems.

Authors:  Joseph D Khoury; Cheryl M Coffin; Sheri L Spunt; James R Anderson; William H Meyer; David M Parham
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

4.  Characterization of alveolar soft part sarcoma using a large national database.

Authors:  Brendan L Hagerty; John Aversa; Laurence P Diggs; Dana A Dominguez; Reed I Ayabe; Andrew M Blakely; Jeremy L Davis; Carrie Luu; Jonathan M Hernandez
Journal:  Surgery       Date:  2020-07-20       Impact factor: 3.982

Review 5.  Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas.

Authors:  Douglas S Hawkins; Sheri L Spunt; Stephen X Skapek
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

6.  PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.

Authors:  Stephen X Skapek; James Anderson; Frederic G Barr; Julia A Bridge; Julie M Gastier-Foster; David M Parham; Erin R Rudzinski; Timothy Triche; Douglas S Hawkins
Journal:  Pediatr Blood Cancer       Date:  2013-03-22       Impact factor: 3.167

7.  The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.

Authors:  Ewa Bien; Malgorzata Rapala; Malgorzata Krawczyk; Anna Balcerska
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-20       Impact factor: 4.553

8.  Pediatric soft tissue sarcoma of the limbs: clinical outcome of 97 patients.

Authors:  Andrea Sambri; Giuseppe Bianchi; Ilaria Cucurnia; Marco Gambarotti; Davide Maria Donati
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-08-01

9.  The impact of 18F-FDG PET on initial staging and therapy planning of pediatric soft-tissue sarcoma patients.

Authors:  Alaa Elmanzalawy; Reza Vali; Govind B Chavhan; Abha A Gupta; Yusuf Omarkhail; Afsaneh Amirabadi; Amer Shammas
Journal:  Pediatr Radiol       Date:  2019-10-18

Review 10.  Overview of the clinical and imaging features of the most common non-rhabdomyosarcoma soft-tissue sarcomas.

Authors:  Simon C Kao
Journal:  Pediatr Radiol       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.